<SUBMISSION>
<SECRELEASE-DATETIME> 20200207-160619 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20200207-160619 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20200207-160527 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001193805-20-000110
<TYPE> 8-K
<PUBLIC-DOCUMENT-COUNT> 5
<PERIOD> 20200206
<ITEMS> 1.01
<ITEMS> 9.01
<FILING-DATE> 20200207
<DATE-OF-FILING-DATE-CHANGE> 20200207
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> ADMA BIOLOGICS, INC.
<CIK> 0001368514
<ASSIGNED-SIC> 2836
<IRS-NUMBER> 562590442 ⇒ 56-2590442 or 562-59-0442
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 8-K
<ACT> 34
<FILE-NUMBER> 001-36728
<FILM-NUMBER> 20587398
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> C/O ADMA BIOLOGICS, INC.
<STREET2> 465 STATE ROUTE 17
<CITY> RAMSEY
<STATE> NJ
<ZIP> 07446
<PHONE> (201) 478-5552
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> C/O ADMA BIOLOGICS, INC.
<STREET2> 465 STATE ROUTE 17
<CITY> RAMSEY
<STATE> NJ
<ZIP> 07446
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> R&R ACQUISITION VI, INC
<DATE-CHANGED> 20060707
</FORMER-COMPANY>
</FILER>
|
<DOCUMENT>
<TYPE> 8-K
<SEQUENCE> 1
<FILENAME> e619325_8k-adma.htm
<TEXT>
<HTML>
Show <HTML>: 265 lines (widest: 190 characters) - 16K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-1.1
<SEQUENCE> 2
<FILENAME> e619325_ex1-1.htm
<TEXT>
<HTML>
Show <HTML>: 2,219 lines (widest: 265 characters) - 200K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-99.1
<SEQUENCE> 3
<FILENAME> e619325_ex99-1.htm
<TEXT>
<HTML>
Show <HTML>: 140 lines (widest: 168 characters) - 11K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-99.2
<SEQUENCE> 4
<FILENAME> e619325_ex99-2.htm
<TEXT>
<HTML>
Show <HTML>: 147 lines (widest: 168 characters) - 11K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 5 ⇐ Not a Document/Exhibit
<FILENAME> image001.jpg
<DESCRIPTION> GRAPHIC
<TEXT>
Show <TEXT>: 171 lines (Unix-to-Unix encoding) - 11K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
